Protagonist Therapeutics Inc
XBER:PGF
Protagonist Therapeutics Inc
XBER:PGF
Price:
75
EUR
Market Closed
Market Cap:
€2.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Protagonist Therapeutics Inc
XBER:PGF
|
US |
|
A
|
Andritz AG
VSE:ANDR
|
AT |
|
Aperam SA
AEX:APAM
|
LU |
Wall St Price Targets
PGF Price Targets Summary
Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Wall Street analysts forecast PGF stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for PGF is 76.2 EUR with a low forecast of 64.17 EUR and a high forecast of 91.39 EUR.
Lowest Forecast
Price Target
64.17
EUR
14% Downside
Average Forecast
Price Target
76.2
EUR
2% Upside
Highest Forecast
Price Target
91.39
EUR
22% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PGF's stock price target?
Price Target
76.2
EUR
76.2
EUR
According to Wall Street analysts, the average 1-year price target for PGF is 76.2 EUR with a low forecast of 64.17 EUR and a high forecast of 91.39 EUR.
What is the Revenue forecast for Protagonist Therapeutics Inc?
Projected CAGR
54%
54%
The compound annual growth rate for Revenue over the next 8 years is 54%.
